Why Seres Therapeutics Stock Is Soaring Today

·2 min read
Why Seres Therapeutics Stock Is Soaring Today

What happened Shares of Seres Therapeutics (NASDAQ: MCRB) were soaring 17.1% higher as of 3:09 p.m. EDT on Wednesday. The big gain came after the company announced that it has achieved its target enrollment of 300 participants in a phase 3 study evaluating SER-109 in treating recurrent C.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting